Ikarian Capital, LLC - 31 Dec 2025 SCHEDULE 13G Report for NextCure, Inc. Common Stock, $0.001 par value per share (NXTC)

Filing Manager
Ikarian Capital, LLC
Reporting Manager
Ikarian Capital, LLC
Security
NextCure, Inc. Common Stock, $0.001 par value per share
Symbol
NXTC
Shares outstanding
3,633,984 shares
Disclosed Ownership
363,035 shares
Ownership
10%
Form type
SCHEDULE 13G
Filing time
17 Feb 2026, 17:28:06 UTC
Date of event
31 Dec 2025
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"Ikarian Capital, LLC disclosed 10% ownership in NextCure, Inc. Common Stock, $0.001 par value per share (NXTC) on 31 Dec 2025."

Quick Takeaways

  • Ikarian Capital, LLC filed SCHEDULE 13G for NextCure, Inc. Common Stock, $0.001 par value per share (NXTC).
  • Disclosed ownership: 10%.
  • Date of event: 31 Dec 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 17 Feb 2026, 17:28.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Ikarian Capital, LLC 10% 363,035 0 363,035 /s/ Neil Shahrestani Neil Shahrestani, Sole Manager
Neil Shahrestani 10% 363,035 0 363,035 /s/ Neil Shahrestani Neil Shahrestani

Sponsored